Sign in
4

Changes in Ownership

MAXCYTE, INC. Filed Acc 0001209191-23-020283

Options or other derivatives

  • Chief Scientific Officer acquired 620,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Sumen Cenk Chief Scientific Officer 2022-04-11 Grant or award · Employee Stock Option (right to buy) +500,000 500,000 D: show line 1 in the form
Sumen Cenk Chief Scientific Officer 2023-03-20 Grant or award · Employee Stock Option (right to buy) +120,000 120,000 D: show line 2 in the form
Loading xslF345X04/doc4.xml…